New Lab at Nemours Center for Childhood Cancer Research
June 6 Dedication Featured The Andrew McDonough B Positive Foundation Donation
Monday, June 13, 2011--Karen Bengston
Wilmington, DE – High-throughput screening technology that drives the discovery of more effective drug therapies is contributing to significant new progress in the treatment of childhood cancers. Recently, a prime example of the growing contributions of high tech robotic equipment was unveiled as philanthropists, health professionals, researchers, and families of children with cancer convened at the Nemours Center for Childhood Cancer Research (NCCCR) for the grand opening of the new High-Throughput Screening Laboratory, which includes equipment purchased through a $250,000 gift from The Andrew McDonough B+ Foundation. NCCCR supports the pediatric cancer program at the Nemours/Alfred I. duPont Hospital for Children and throughout Nemours.
“Exciting work is being done to apply the power of robotic equipment to finding better therapies for childhood cancers,” said A. K. Rajasekaran, PhD, Director of NCCCR, one of just a few pediatric facilities using the devices. The new equipment allows very rapid screening of hundreds of thousands of chemical compounds to find potential therapeutic matches that block the effects of cancer-causing proteins. What used to take months will now take hours. “The grand opening ceremony afforded us the opportunity to showcase next-generation research and thank the B+ Foundation for its tremendous support as we continue to battle pediatric cancer,” he said.
Joe McDonough, President of The Andrew McDonough B+ Foundation, unveiled the plaque that will be installed in the lab to commemorate the donation made in honor of Andrew. McDonough lost his son in 2007. “It was not the cancer but the treatment and subsequent infection that ultimately caused Andrew’s death,” McDonough said. “The foundation’s goal is to support research that will contribute to better therapies, less suffering and better outcomes for kids.” Through fundraising efforts, B+ raised $250,000 for the purchase of the robotic equipment.
Nemours, one of the nation’s leading pediatric health systems, is dedicated to achieving higher standards in children’s health by offering a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to all families in the communities it serves. Starting with Alfred I. duPont’s bequest over seventy years ago, Nemours has grown into a multi-dimensional organization offering personalized clinical and preventive care focused on children.
Nemours owns and operates the Alfred I. duPont Hospital for Children in Wilmington, Delaware and major children’s specialty clinics in Delaware (Wilmington), Florida (Jacksonville, Orlando and Pensacola), Pennsylvania (Philadelphia, Lancaster and Newtown Square) and New Jersey (Egg Harbor Township and Voorhees). Nemours will establish a new full-service children’s hospital in Orlando in 2012. KidsHealth.org, the world’s most visited pediatric health care Web site for parents, kids and teens, is a project of Nemours.
Nemours employs over 4,100 individuals, including 430 pediatric physicians, specialists and surgeons who cared for almost a quarter of a million children in 2009. The organization’s goal is to align with parents, physicians, community leaders, children’s advocates and elected officials to ensure optimal wellness for every child. For more information about Nemours, please visit www.nemours.org.